media – Page 579 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Illumina and KingMed to develop oncology diagnostics in China

US-based gene sequencing firm Illumina has signed an agreement with Guangzhou KingMed Diagnostics Group to co-develop new oncology and hereditary disease testing applications in China.
- Source: Verdict Medical Devices
- 640
- January 9, 2018
cancer CFDA Company Insight digital health
J&J signs 15 deals for new healthcare solutions

Johnson & Johnson (J&J) has signed 15 new partnerships to explore, develop and advance new medical devices, therapeutics and consumer health solutions.
- Source: Verdict Medical Devices
- 706
- January 9, 2018
AI cancer Company Insight Johnson & Johnson
Roche introduces new sample collection device for HIV plasma viral load testing

The new card solution helps to simplify blood collection and sample transportation through providing a small amount of a patient’s blood from a fingertip.
- Source: MDBR
- 506
- January 9, 2018
Company Insight HIV Roche
Shire’s cytomegalovirus therapy wins ‘Breakthrough’ status

An experimental drug being developed by Shire to treat cytomegalovirus (CMV) infection has been given a boost in the US with a ‘Breakthrough Therapy Designation’.
- Source: pharmatimes
- 512
- January 8, 2018
Company Insight compromised immunity cytomegalovirus virus
Addex, Indivior Forge $335M Addiction Disorder Tie-Up

Indivior announced that Indivior UK Limited has entered into a strategic collaboration with Addex Pharma S.A., a wholly-owned subsidiary of Addex Therapeutics (SIX: ADXN) ("Addex"), in the field of GABAB positive allosteric modulators (PAMs). GABAB PAMs have demonstrated preclinical efficacy and tolerability in animal models for alcohol use disorder (AUD) and cocaine use disorder (CUD)1,2.
- Source: Biospace
- 421
- January 8, 2018
AUD CUD GABAB PAM Market Views
Pfizer, Arvinas Forge $830M Protein Degradation R&D Deal

Two months after expanding a licensing deal with Genentech, privately-held Arvinas LLC struck another lucrative deal with a major pharmaceutical company. Connecticut-based Arvinas inked a deal with Pfizer worth up to $830 million to develop small molecules that can degrade proteins.
- Source: Biospace
- 526
- January 8, 2018
Genentech Pfizer pharmaceutical company PROTAC small molecule therapeutics
Microsoft and Adaptive Biotech to create universal blood test using AI

Microsoft has partnered with and invested in US-based Adaptive Biotechnologies to map the human immune system genetics using artificial intelligence (AI) for early detection and diagnosis of multiple diseases, including cancer.
- Source: Verdict Medical Devices
- 524
- January 8, 2018
AI Company Insight Microsoft
Surgery death rates in Africa are twice global average

The risk of dying from scheduled surgery in Africa is more than double the global average, researchers said on Wednesday, in a study shedding light on one of the continent's biggest but poorly investigated healthcare problems.
- Source: msn
- 611
- January 8, 2018
healthcare Researches Surgery death
FDA approves Mevion’s Hyperscan pencil beam scanning technology

Mevion S250i is a compact proton therapy system that has the capacity to deliver conformal radiation therapy treatments with the support of Hyperscan pencil beam scanning technology.
- Source: MDBR
- 543
- January 8, 2018
Company Insight FDA medical device
Next-generation medical scanning

Researchers have developed a new way to magnetise molecules found naturally in the human body, paving the way for a new generation of low-cost magnetic resonance imaging (MRI) technology that would transform our ability to diagnose and treat diseases including cancer, diabetes and dementia.
- Source: ScienceDaily
- 522
- January 8, 2018
medical device MRI Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.